Edition:
India

Nichi-Iko Pharmaceutical Co Ltd (4541.T)

4541.T on Tokyo Stock Exchange

1,695JPY
18 May 2018
Change (% chg)

¥-2 (-0.12%)
Prev Close
¥1,697
Open
¥1,694
Day's High
¥1,703
Day's Low
¥1,684
Volume
372,900
Avg. Vol
328,818
52-wk High
¥1,801
52-wk Low
¥1,570

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -- March 23 May 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 2 2 1 1
(3) HOLD 3 3 3 3
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.60 2.60 2.75 2.75

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Mar-18 4 186,700.00 193,600.00 169,000.00 --
Year Ending Mar-19 4 199,100.00 210,900.00 175,000.00 238,767.00
Year Ending Mar-20 4 218,900.00 250,700.00 184,000.00 251,100.00
Earnings (per share)
Year Ending Mar-18 5 115.25 136.88 102.46 --
Year Ending Mar-19 5 127.81 152.87 108.84 152.50
Year Ending Mar-20 5 147.15 170.65 122.70 163.20
LT Growth Rate (%) 1 21.16 21.16 21.16 --

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 51,487.00 45,784.00 5,703.00 11.08
Quarter Ending Mar-17 50,425.00 46,097.00 4,328.00 8.58
Quarter Ending Mar-16 34,480.00 35,193.00 713.00 2.07
Quarter Ending Sep-15 34,451.00 33,938.00 513.00 1.49
Quarter Ending Jun-15 33,266.00 35,049.00 1,783.00 5.36

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Mar-18 186,700.00 -- -- -- --
Year Ending Mar-19 199,100.00 199,100.00 204,560.00 203,975.00 238,767.00
Year Ending Mar-20 218,900.00 218,900.00 223,420.00 216,600.00 251,100.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Mar-18 -- -- -- --
Year Ending Mar-19 0 0 0 0
Year Ending Mar-20 0 0 0 0
Earnings